Clinical Trial Update: Effects of Dapagliflozin on EChOcardiographic Measures of CarDiac StructurE and Function in Patients with CKD [Phase 2]

View source ↗

Summary

Phase 2 clinical trial assessing whether dapagliflozin improves echocardiographic measures of cardiac structure and function in patients with chronic kidney dis…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Chronic Kidney Disease

Drugs mentioned

• Dapagliflozin (dapagliflozin)

Snippet

Sponsor: Tor Biering-Sørensen | Conditions: Chronic Kidney Diseases | Phase 2 | Status: RECRUITING